Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Beacon Equity Research Featured Company: Caleco Pharma Corp. (CAEH.OB)

Caleco Pharma develops bio-pharmaceutical and consumer health products, leveraging proprietary “Liver Health” formulations of natural, plant-based (Lamiridosin) extracts to simultaneously pursue a dual pathway model for OTC and prescription commercialization.

The Lamiridosin Franchise consists of the wide range of other products, from nutraceuticals and oral supplements that promote liver health or boost the immune system, to a bevy of dermatological and topical hair care products for the skin and scalp.

Partnerships with Madrid-based Natac Biotech (plant extracts/probiotics), the Universidad Autónoma de Madrid (30 scientists/research facilities), and Rearden Health Partners (product development consultancy) give Caleco Pharma the kind of logistical network needed to maximize product commercialization, both near-term OTC and long-term prescription.

Please see disclaimer on QualityStocks website: disclaimer.qualitystocks.net


Disclosure: no positions